Results 261 to 270 of about 237,941 (312)
Some of the next articles are maybe not open access.

Bioavailability of dexamethasone; II. Dexamethasone phosphate

Clinical Pharmacology & Therapeutics, 1975
Plasma levels of dexamethasone phosphate (DP) and dexamethasone free alcohol (DA) were determined by a modification of existing radioimmunoassay methodology following intravenous administration of DP in man. Areas under DA plasma profiles were a linear function of DP dosage over the 40‐fold range 0.05 to 2.0 mg/kg, and, by comparison with values ...
K. C. Yeh   +4 more
openaire   +3 more sources

Dexamethasone in Dermatology

Archives of Dermatology, 1959
Dexamethasone is 9-α-fluoro,16-α-methylprednisolone. * It is one of a group of prednisolone analogues synthesized and studied by Arth and his co-workers 1,2 in the continuing search for modifications of hydrocortisone which would afford increased anti-inflammatory and antiallergic activity but would produce minimal mineral imbalance and the other ...
Blau S, Norman B. Kanof
openaire   +3 more sources

Dexamethasone in adenotonsillectomy

International Journal of Pediatric Otorhinolaryngology, 1996
Edema contributes substantially to the postoperative discomfort and morbidity of adenotonsillectomy. In a double-blind study, 58 children undergoing adenotonsillectomy were given a single intraoperative dose of either dexamethasone or saline. The steroid markedly affected the postoperative course in the first day after surgery.
Josephine J. Templeton   +3 more
openaire   +3 more sources

Dexamethasone and Osteonecrosis

Australian and New Zealand Journal of Medicine, 1981
Abstract: Four cases are reported in whom osteonecrosis followed after Dexamethasone was administered in high dosage for a short time to mduce cerebral and spinal cord oedema. Although corticosteroids have been implicated in the development of osteonecrosis, the delay from corticosteroid administration to the development of symptoms (9–30 months ...
K. A. Black, E. T. Owen, M. S. Khangure
openaire   +3 more sources

Plasma dexamethasone concentrations and the dexamethasone suppression test

Biological Psychiatry, 1990
Altered bioavailability or altered pharmacokinetics of dexamethasone (dex) may contribute to a positive Dexamethasone Suppression Test (DST) in psychiatric patients. We measured plasma dex and plasma cortisol concentrations in 32 patients with primary major depressive disorder (MDD), 14 patients with other psychiatric disorders, and 16 normal controls.
K. Ranga   +5 more
openaire   +3 more sources

The dexamethasone suppression test: Importance of dexamethasone concentrations

Biological Psychiatry, 1987
Plasma dexamethasone concentrations and cortisol response to dexamethasone were measured in 29 normal healthy volunteers, 23 depressed patients, and 10 patients with anorexia nervosa at 4:00 PM postdexamethasone. In each of the 3 groups, nonsuppressors had lower dexamethasone concentrations than suppressors. Of the subjects with plasma dexamethasone at
N. Biddle   +4 more
openaire   +3 more sources

Dexamethasone Suppression Test and Plasma Dexamethasone Levels in Bulimia

Archives of General Psychiatry, 1987
A 1-mg dexamethasone suppression test (DST) was carried out in 66 women with bulimia and in 26 age- and sex-matched controls. Blood samples were obtained at 4 PM on the day following dexamethasone ingestion, and levels of cortisol and of dexamethasone in the plasma were measured.
David C. Lindy   +6 more
openaire   +3 more sources

Shortened Dexamethasone Half-life in Depressed Dexamethasone Nonsuppressors

Archives of General Psychiatry, 1986
To the Editor.— A variety of technical and medical factors have been identified that may invalidate results of the dexamethasone suppression test (DST). Our unit1,2and other investigators3-5have reported that plasma dexamethasone concentrations were significantly lower in DST nonsuppressors than in suppressors.
Klaus Wiedemann   +2 more
openaire   +3 more sources

The effect of serum dexamethasone concentrations in the dexamethasone suppression test

Biological Psychiatry, 1986
Serum dexamethasone and cortisol concentrations were measured in a sample of 98 psychiatric inpatients during the course of the 1-mg oral overnight Dexamethasone Suppression Test (DST). Suppressors were found to have significantly higher serum dexamethasone concentrations than nonsuppressors at each time of sampling (8:00 AM, 4:00 PM, and 11:00 PM ...
Vaughan J. Carr   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy